(Q40396100)

20 September 2017

title

Management of secondary hyperparathyroidism (English)

1 reference

20 September 2017

1 reference

John Cunningham

1

1 reference

20 September 2017

publication date

1 August 2005

1 reference

Therapeutic Apheresis and Dialysis

20 September 2017

published in

1 reference

20 September 2017

volume

9 Suppl 1

1 reference

20 September 2017

page(s)

S35-40

1 reference

Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK)

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2005.00310.X

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2005.00310.X

The PTH-calcium curve and the set point of calcium in primary and secondary hyperparathyroidism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2005.00310.X

Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2005.00310.X

Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2005.00310.X

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2005.00310.X

Biochemical and cellular effects of direct maxacalcitol injection into parathyroid gland in uremic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2005.00310.X

10.1111/J.1744-9987.2005.00310.X

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference